7 Einträge gefunden

1. Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial

   1. Pohl-Rescigno, Esther
   2. Hauke, Jan
   3. Loibl, Sibylle
   4. Möbus, Volker
   5. Denkert, Carsten
   6. Fasching, Peter A
   7. Kayali, Mohamad

   2020 - Forschungsinformationssystem des UKE
2. Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

   1. Laakmann, Elena
   2. Emons, Julius
   3. Taran, Florin-Andrei
   4. Janni, Wolfgang
   5. Uhrig, Sabrina
   6. Overkamp, Friedrich
   7. Kolberg, Hans-Christian

   2020 - Forschungsinformationssystem des UKE
3. Clinical endpoints in real-world registry studies:PRAEGNANT network for women with advanced breast cancer, Klinische Endpunkte in Real-World-Register-Studien: PRAEGNANT-Netzwerk für Patientinnen mit fortgeschrittenem Mammakarzinom

   1. Hartkopf, Andreas D.
   2. Emons, Julius
   3. Lux, Michael P.
   4. Taran, Florin Andrei
   5. Overkamp, Friedrich
   6. Tesch, Hans
   7. Titzmann, Adriana

   2020 - Forschungsinformationssystem des UKE
4. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

   1. Tesch, Hans
   2. Müller, Volkmar
   3. Wöckel, Achim
   4. Ettl, Johannes
   5. Belleville, Erik
   6. Schütz, Florian
   7. Hartkopf, Andreas

   2020 - Forschungsinformationssystem des UKE
5. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

   1. Huebner, Hanna
   2. Kurbacher, Christian M
   3. Kuesters, Geoffrey
   4. Hartkopf, Andreas D
   5. Lux, Michael P
   6. Huober, Jens
   7. Volz, Bernhard

   2020 - Forschungsinformationssystem des UKE
6. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer:Data From the GeparOcto-GBG 84 Trial

   1. Rüger, Alexandra Maria
   2. Schneeweiss, Andreas
   3. Seiler, Sabine
   4. Tesch, Hans
   5. van Mackelenbergh, Marion
   6. Marmé, Frederik
   7. Lübbe, Kristina

   2020 - Forschungsinformationssystem des UKE
7. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

   1. Michel, Laura L
   2. Hartkopf, Andreas D
   3. Fasching, Peter A
   4. Kolberg, Hans-Christian
   5. Hadji, Peyman
   6. Tesch, Hans
   7. Häberle, Lothar

   2020 - Forschungsinformationssystem des UKE